Repros Therapeutics Inc.

CIK 897075 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Repros Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2019SC 13G/A0001019056-19-000119
Feb 13, 2018SC 13G/A0000315066-18-001542
Feb 9, 201815-12B0001193125-18-037317
Feb 6, 2018EFFECT9999999995-18-000341
Feb 6, 2018EFFECT9999999995-18-000342
Feb 6, 2018EFFECT9999999995-18-000340
Feb 6, 2018EFFECT9999999995-18-000338
Feb 6, 2018EFFECT9999999995-18-000339
Jan 31, 201840001144204-18-004789
Jan 31, 2018S-8 POS0001144204-18-004775
Jan 31, 2018POS AM0001144204-18-004760
Jan 31, 2018POS AM0001144204-18-004758
Jan 31, 2018POS AM0001144204-18-004751
Jan 31, 201840001144204-18-004787
Jan 31, 201825-NSE0001354457-18-000018
Jan 31, 2018POS AM0001144204-18-004756
Jan 31, 2018S-8 POS0001144204-18-004770
Jan 31, 2018POS AM0001144204-18-004754
Jan 31, 2018S-8 POS0001144204-18-004767
Jan 31, 201840001144204-18-004781
Jan 31, 20188-K0001144204-18-004748
Jan 31, 201840001144204-18-004779
Jan 31, 2018S-8 POS0001144204-18-004773
Jan 31, 2018S-8 POS0001144204-18-004762
Jan 31, 201840001144204-18-004777